Richards WA

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

6 papers · 1 preprint · ORCID

ArticlePsilocybin

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Stocker K, Hartmann M, Barrett FS +6

Europe PMC2026
ArticlePsilocybin

Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.

Griffiths RR, Jesse R, Richards WA +4

Europe PMC2025
ArticlePsilocybin

The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics.

Majić T, Schmidt TT, Gröticke A +4

Europe PMC2025
PreprintPsilocybin

The Afterglow Inventory (AGI) – validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics

Majic T, Schmidt TT, Gröticke A +4

Europe PMC2024
ArticlePsilocybin

Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

Rosa WE, Sager Z, Miller M +19

Europe PMC2022
ArticlePsilocybin

Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.

Tai SJ, Nielson EM, Lennard-Jones M +7

Europe PMC2021
ArticlePsilocybin

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.

Garcia-Romeu A, Richards WA

Europe PMC2018